Elevated hepatic iron activates NF-E2-related factor 2-regulated pathway in a dietary iron overload mouse model

Mi Sun Moon, Emily I. Mcdevitt, Junjia Zhu, Bruce Stanley, Jacek Krzeminski, Shantu Amin, Cesar Aliaga, Thomas G. Miller, Harriet C. Isom

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Hepatic iron overload has been associated classically with the genetic disorder hereditary hemochromatosis. More recently, it has become apparent that mild-to-moderate degrees of elevated hepatic iron stores observed in other liver diseases also have clinical relevance. The goal was to use a mouse model of dietary hepatic iron overload and isobaric tag for relative and absolute quantitation proteomics to identify, at a global level, differentially expressed proteins in livers from mice fed a control or 3,5,5-trimethyl-hexanoyl-ferrocene (TMHF) supplemented diet for 4 weeks. The expression of 74 proteins was altered by ≥ ±1.5-fold, showing that the effects of iron on the liver proteome were extensive. The top canonical pathway altered by TMHF treatment was the NF-E2-related factor 2 (NRF2-)-mediated oxidative stress response. Because of the long-standing association of elevated hepatic iron with oxidative stress, the remainder of the study was focused on NRF2. TMHF treatment upregulated 25 phase I/II and antioxidant proteins previously categorized as NRF2 target gene products. Immunoblot analyses showed that TMHF treatment increased the levels of glutathione S-transferase (GST) M1, GSTM4, glutamate-cysteine ligase (GCL) catalytic subunit, GCL modifier subunit, glutathione synthetase, glutathione reductase, heme oxygenase 1, epoxide hydrolase 1, and NAD(P)H dehydrogenase quinone 1. Immunofluorescence, carried out to determine the cellular localization of NRF2, showed that NRF2 was detected in the nucleus of hepatocytes from TMHF-treated mice and not from control mice. We conclude that elevated hepatic iron in a mouse model activates NRF2, a key regulator of the cellular response to oxidative stress.

Original languageEnglish (US)
Pages (from-to)74-85
Number of pages12
JournalToxicological Sciences
Volume129
Issue number1
DOIs
StatePublished - Sep 1 2012

Fingerprint

NF-E2-Related Factor 2
Dietary Iron
Iron Overload
Iron
Oxidative stress
Liver
Glutamate-Cysteine Ligase
Oxidative Stress
Glutathione Synthase
NAD(P)H Dehydrogenase (Quinone)
Epoxide Hydrolases
Proteins
Heme Oxygenase-1
Glutathione Reductase
Proteome
Inborn Genetic Diseases
Nutrition
Hemochromatosis
Proteomics
Antioxidants

All Science Journal Classification (ASJC) codes

  • Toxicology

Cite this

@article{2ca1b02acc1447918a5ce98cb9eeab39,
title = "Elevated hepatic iron activates NF-E2-related factor 2-regulated pathway in a dietary iron overload mouse model",
abstract = "Hepatic iron overload has been associated classically with the genetic disorder hereditary hemochromatosis. More recently, it has become apparent that mild-to-moderate degrees of elevated hepatic iron stores observed in other liver diseases also have clinical relevance. The goal was to use a mouse model of dietary hepatic iron overload and isobaric tag for relative and absolute quantitation proteomics to identify, at a global level, differentially expressed proteins in livers from mice fed a control or 3,5,5-trimethyl-hexanoyl-ferrocene (TMHF) supplemented diet for 4 weeks. The expression of 74 proteins was altered by ≥ ±1.5-fold, showing that the effects of iron on the liver proteome were extensive. The top canonical pathway altered by TMHF treatment was the NF-E2-related factor 2 (NRF2-)-mediated oxidative stress response. Because of the long-standing association of elevated hepatic iron with oxidative stress, the remainder of the study was focused on NRF2. TMHF treatment upregulated 25 phase I/II and antioxidant proteins previously categorized as NRF2 target gene products. Immunoblot analyses showed that TMHF treatment increased the levels of glutathione S-transferase (GST) M1, GSTM4, glutamate-cysteine ligase (GCL) catalytic subunit, GCL modifier subunit, glutathione synthetase, glutathione reductase, heme oxygenase 1, epoxide hydrolase 1, and NAD(P)H dehydrogenase quinone 1. Immunofluorescence, carried out to determine the cellular localization of NRF2, showed that NRF2 was detected in the nucleus of hepatocytes from TMHF-treated mice and not from control mice. We conclude that elevated hepatic iron in a mouse model activates NRF2, a key regulator of the cellular response to oxidative stress.",
author = "Moon, {Mi Sun} and Mcdevitt, {Emily I.} and Junjia Zhu and Bruce Stanley and Jacek Krzeminski and Shantu Amin and Cesar Aliaga and Miller, {Thomas G.} and Isom, {Harriet C.}",
year = "2012",
month = "9",
day = "1",
doi = "10.1093/toxsci/kfs193",
language = "English (US)",
volume = "129",
pages = "74--85",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

Elevated hepatic iron activates NF-E2-related factor 2-regulated pathway in a dietary iron overload mouse model. / Moon, Mi Sun; Mcdevitt, Emily I.; Zhu, Junjia; Stanley, Bruce; Krzeminski, Jacek; Amin, Shantu; Aliaga, Cesar; Miller, Thomas G.; Isom, Harriet C.

In: Toxicological Sciences, Vol. 129, No. 1, 01.09.2012, p. 74-85.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Elevated hepatic iron activates NF-E2-related factor 2-regulated pathway in a dietary iron overload mouse model

AU - Moon, Mi Sun

AU - Mcdevitt, Emily I.

AU - Zhu, Junjia

AU - Stanley, Bruce

AU - Krzeminski, Jacek

AU - Amin, Shantu

AU - Aliaga, Cesar

AU - Miller, Thomas G.

AU - Isom, Harriet C.

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Hepatic iron overload has been associated classically with the genetic disorder hereditary hemochromatosis. More recently, it has become apparent that mild-to-moderate degrees of elevated hepatic iron stores observed in other liver diseases also have clinical relevance. The goal was to use a mouse model of dietary hepatic iron overload and isobaric tag for relative and absolute quantitation proteomics to identify, at a global level, differentially expressed proteins in livers from mice fed a control or 3,5,5-trimethyl-hexanoyl-ferrocene (TMHF) supplemented diet for 4 weeks. The expression of 74 proteins was altered by ≥ ±1.5-fold, showing that the effects of iron on the liver proteome were extensive. The top canonical pathway altered by TMHF treatment was the NF-E2-related factor 2 (NRF2-)-mediated oxidative stress response. Because of the long-standing association of elevated hepatic iron with oxidative stress, the remainder of the study was focused on NRF2. TMHF treatment upregulated 25 phase I/II and antioxidant proteins previously categorized as NRF2 target gene products. Immunoblot analyses showed that TMHF treatment increased the levels of glutathione S-transferase (GST) M1, GSTM4, glutamate-cysteine ligase (GCL) catalytic subunit, GCL modifier subunit, glutathione synthetase, glutathione reductase, heme oxygenase 1, epoxide hydrolase 1, and NAD(P)H dehydrogenase quinone 1. Immunofluorescence, carried out to determine the cellular localization of NRF2, showed that NRF2 was detected in the nucleus of hepatocytes from TMHF-treated mice and not from control mice. We conclude that elevated hepatic iron in a mouse model activates NRF2, a key regulator of the cellular response to oxidative stress.

AB - Hepatic iron overload has been associated classically with the genetic disorder hereditary hemochromatosis. More recently, it has become apparent that mild-to-moderate degrees of elevated hepatic iron stores observed in other liver diseases also have clinical relevance. The goal was to use a mouse model of dietary hepatic iron overload and isobaric tag for relative and absolute quantitation proteomics to identify, at a global level, differentially expressed proteins in livers from mice fed a control or 3,5,5-trimethyl-hexanoyl-ferrocene (TMHF) supplemented diet for 4 weeks. The expression of 74 proteins was altered by ≥ ±1.5-fold, showing that the effects of iron on the liver proteome were extensive. The top canonical pathway altered by TMHF treatment was the NF-E2-related factor 2 (NRF2-)-mediated oxidative stress response. Because of the long-standing association of elevated hepatic iron with oxidative stress, the remainder of the study was focused on NRF2. TMHF treatment upregulated 25 phase I/II and antioxidant proteins previously categorized as NRF2 target gene products. Immunoblot analyses showed that TMHF treatment increased the levels of glutathione S-transferase (GST) M1, GSTM4, glutamate-cysteine ligase (GCL) catalytic subunit, GCL modifier subunit, glutathione synthetase, glutathione reductase, heme oxygenase 1, epoxide hydrolase 1, and NAD(P)H dehydrogenase quinone 1. Immunofluorescence, carried out to determine the cellular localization of NRF2, showed that NRF2 was detected in the nucleus of hepatocytes from TMHF-treated mice and not from control mice. We conclude that elevated hepatic iron in a mouse model activates NRF2, a key regulator of the cellular response to oxidative stress.

UR - http://www.scopus.com/inward/record.url?scp=84865762072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865762072&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfs193

DO - 10.1093/toxsci/kfs193

M3 - Article

C2 - 22649188

AN - SCOPUS:84865762072

VL - 129

SP - 74

EP - 85

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -